Panacea Index Logo

Command Palette

Search for a command to run...

Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.

Gastroenterology
July 1, 2024
Karen Van den Houte et al. (18 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to objectively identify FODMAP triggers through a blinded reintroduction phase and evaluate the impact on symptoms, quality of life, and psychosocial comorbidities in IBS patients.

Results Summary

The low-FODMAP diet significantly improved IBS symptoms (80% responders), with fructans and mannitol being the most prevalent triggers. Symptom recurrence occurred in 85% of FODMAP reintroductions, with specific timing for symptom onset depending on the FODMAP type.

Population

117 patients with irritable bowel syndrome (IBS) from a tertiary-care setting.

Effective Dosage

Not specified (FODMAP powders used in reintroduction phase).

Duration

6-week elimination period followed by a 9-week reintroduction phase.

Interactions

None mentioned

Extracted Claims (15)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) diet
neutral
efficacy in irritable bowel syndrome (IBS)
patients with IBS
-
is well established
#1
low FODMAP diet
decrease
IBS symptom severity score (IBS-SSS)
117 recruited patients with IBS
150 ± 116 vs 301 ± 97
improved significantly
#2
low FODMAP diet
decrease
symptoms
tertiary-care IBS patients
-
significant benefit
#3
FODMAP powders (fructans, fructose, galacto-oligosaccharides, lactose, mannitol, sorbitol)
increase
symptoms
responders to a 6-week low FODMAP diet
85% of the FODMAP powders
triggered symptom recurrence
#4
FODMAP powders
increase
symptoms
responders to a 6-week low FODMAP diet
average of 2.5 ± 2 FODMAPs/patient
triggered symptom recurrence
#5
fructans
increase
symptom recurrence
responders to a 6-week low FODMAP diet
56%
most prevalent trigger
#6
mannitol
increase
symptom recurrence
responders to a 6-week low FODMAP diet
54%
most prevalent trigger
#7
galacto-oligosaccharides
increase
symptom recurrence
responders to a 6-week low FODMAP diet
35%
trigger
#8
lactose
increase
symptom recurrence
responders to a 6-week low FODMAP diet
28%
trigger
#9
fructose
increase
symptom recurrence
responders to a 6-week low FODMAP diet
27%
trigger
#10
sorbitol
increase
symptom recurrence
responders to a 6-week low FODMAP diet
23%
trigger
#11
glucose
increase
symptom recurrence
responders to a 6-week low FODMAP diet
26%
trigger
#12
sorbitol/mannitol
increase
abdominal pain
responders to a 6-week low FODMAP diet
day 1
significant increase
#13
fructans/galacto-oligosaccharides
increase
abdominal pain
responders to a 6-week low FODMAP diet
day 2
significant increase
#14
lactose
increase
abdominal pain
responders to a 6-week low FODMAP diet
day 3
significant increase
#15
Abstract

BACKGROUND & AIMS: The efficacy of a low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) diet in irritable bowel syndrome (IBS) is well established. After the elimination period, a reintroduction phase aims to identify triggers. We studied the impact of a blinded reintroduction using FODMAP powders to objectively identify triggers and evaluated the effect on symptoms, quality of life, and psychosocial comorbidities. METHODS: Responders to a 6-week low FODMAP diet, defined by a drop in IBS symptom severity score (IBS-SSS) compared with baseline, entered a 9-week blinded randomized reintroduction phase with 6 FODMAP powders (fructans, fructose, galacto-oligosaccharides, lactose, mannitol, sorbitol) or control (glucose). A rise in IBS-SSS (≥50 points) defined a FODMAP trigger. Patients completed daily symptom diaries and questionnaires for quality of life and psychosocial comorbidities. RESULTS: In 117 recruited patients with IBS, IBS-SSS improved significantly after the elimination period compared with baseline (150 ± 116 vs 301 ± 97, P < .0001, 80% responders). Symptom recurrence was triggered in 85% of the FODMAP powders, by an average of 2.5 ± 2 FODMAPs/patient. The most prevalent triggers were fructans (56%) and mannitol (54%), followed by galacto-oligosaccharides, lactose, fructose, sorbitol, and glucose (respectively 35%, 28%, 27%, 23%, and 26%) with a significant increase in abdominal pain at day 1 for sorbitol/mannitol, day 2 for fructans/galacto-oligosaccharides, and day 3 for lactose. CONCLUSION: We confirmed the significant benefit of the low FODMAP diet in tertiary-care IBS. A blinded reintroduction revealed a personalized pattern of symptom recurrence, with fructans and mannitol as the most prevalent, and allows the most objective identification of individual FODMAP triggers. Ethical commission University hospital of Leuven reference number: s63629; Clinicaltrials.gov number: NCT04373304.

Medical Subject Headings (MeSH)
HumansIrritable Bowel SyndromeFemaleMaleAdultQuality of LifeMiddle AgedOligosaccharidesFermentationMannitolDiet, Carbohydrate-RestrictedTreatment OutcomeLactoseMonosaccharidesDisaccharidesPolymersFructoseSorbitolFructansSeverity of Illness IndexDouble-Blind MethodSurveys and QuestionnairesPowdersRecurrenceYoung AdultFODMAP Diet
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality90/10
Citation Metrics
Total Citations10
Citations/Year10.0
Relative Citation Ratio3.94
Research Impact Scores
APT Score0.75
Weight Score3.25
Normalized Score0.72
Related Supplements
Efficacy and Findings of a Blinded Randomized Reintroduction... | Panacea Index